Reviewers: LI Ya-jun, LIU Yu-ting, ZHOU Hui, GUO Han-guo. Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 80-82. DOI: 10.12019/j.issn.1671-5144.2020.02.004
|
Citation:
|
Reviewers: LI Ya-jun, LIU Yu-ting, ZHOU Hui, GUO Han-guo. Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 80-82. DOI: 10.12019/j.issn.1671-5144.2020.02.004
|
Reviewers: LI Ya-jun, LIU Yu-ting, ZHOU Hui, GUO Han-guo. Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 80-82. DOI: 10.12019/j.issn.1671-5144.2020.02.004
|
Citation:
|
Reviewers: LI Ya-jun, LIU Yu-ting, ZHOU Hui, GUO Han-guo. Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 80-82. DOI: 10.12019/j.issn.1671-5144.2020.02.004
|
DownLoad: